News
NITO
1.590
-5.36%
-0.090
N2OFF accelerates European renewable energy momentum
TipRanks · 12/29/2025 13:35
N2OFF Collaborates With Solterra Renewable Energy To Enhance European Portfolio
Benzinga · 12/29/2025 13:25
N2OFF Advances German and Italian Renewable Projects with Key Regulatory Submissions
Reuters · 12/29/2025 13:22
Weekly Report: what happened at NITO last week (1222-1226)?
Weekly Report · 12/29/2025 09:37
Weekly Report: what happened at NITO last week (1215-1219)?
Weekly Report · 12/22/2025 09:37
N2OFF Holds Successful Annual General Meeting
TipRanks · 12/16/2025 22:05
Weekly Report: what happened at NITO last week (1208-1212)?
Weekly Report · 12/15/2025 09:40
Weekly Report: what happened at NITO last week (1201-1205)?
Weekly Report · 12/08/2025 09:40
Weekly Report: what happened at NITO last week (1124-1128)?
Weekly Report · 12/01/2025 09:38
Weekly Report: what happened at NITO last week (1117-1121)?
Weekly Report · 11/24/2025 09:41
N2OFF shares update from CEO Silberman
TipRanks · 11/18/2025 14:41
N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination
Barchart · 11/18/2025 08:12
Weekly Report: what happened at NITO last week (1110-1114)?
Weekly Report · 11/17/2025 09:41
Weekly Report: what happened at NITO last week (1103-1107)?
Weekly Report · 11/10/2025 09:39
Weekly Report: what happened at NITO last week (1027-1031)?
Weekly Report · 11/03/2025 09:39
N2OFF completes merger with MitoCareX Bio
TipRanks · 10/30/2025 13:32
N2OFF COMPLETED MERGER WITH CANCER DRUG DISCOVERY COMPANY TARGETING TOUGH-TO-TREAT PANCREATIC AND LUNG CANCERS
Reuters · 10/30/2025 13:25
*N2OFF Completes Merger With MitoCareX Bio Ltd. >NITO
Dow Jones · 10/30/2025 13:25
*N2OFF Completed Merger With Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic And Lung Cancers >NITO
Dow Jones · 10/30/2025 13:25
N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers
Barchart · 10/30/2025 08:25
More
Webull provides a variety of real-time NITO stock news. You can receive the latest news about N2OFF INC through multiple platforms. This information may help you make smarter investment decisions.
About NITO
N2OFF, Inc. is a cleantech company mainly engaged in European Union (EU) based solar assets using the Ready to Build (RTB) business model. The Company is an investor in four solar projects in three different EU countries. It collaborates with Solterra Renewable Energy Ltd., an Israeli corporation and a wholly owned subsidiary of Solterra Energy Ltd., an Israeli corporation, which operates in the solar energy sector and presents certain investment opportunities in solar photovoltaic (PV) projects. The Company also controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatments in fruit and vegetables to control and prevent pathogen contamination. The Company’s solutions are focused on improving the food safety and shelf life of fresh produce. The Company, through its subsidiary, MitoCareX Bio Ltd., is focused on the development of novel therapies for hard-to-treat cancers by targeting proteins belonging to the mitochondrial SLC25 protein family.